A standards-compliant, terminal-based solution to relay attacks on NFC. Prevent contactless card fraud from the growing threat of this attack vector.
Near Field Communication (NFC), the technology behind contactless debit/credit cards and some access control card systems, has long been known to be vulnerable to relay attacks. Until recently, this attack vector posed minimal threat as only a handful of experts in the field had the necessary resources and knowledge to undertake this attack. Now, anyone with an NFC-enabled Android smartphone can download an app that enables them to carry out a relay attack – with limited-to-no expert knowledge required by the attacker. Combined with the rapid roll-out of contactless cards by financial institutions, the risk this attack presents is substantial and can no longer be ignored. Indeed, news reports of this vulnerability being exploited have started to become more frequent. It is imperative that this security flaw is patched to protect cardholders, retailers, and financial institutions from becoming victims of contactless payment fraud.
Next generation enzyme-functionalized nano-bead system for biofilm dispersion
A new, cost-effective and environmental friendly method of removing unwanted biofilms from industrial scale surfaces. The patented technology is based on the use of enzyme-functionalised nano-beads as a non-corrosive and environmentally friendly anti-biofilm and anti-fouling agents
Avoid Malfunctions & Reduced Reliability. Increase Accuracy & Resolution.
The accumulation of charge in the dielectric of a MEMS (Micro Electro Mechanical Systems) device results in a parasitic source of electrostatic force which, if uncontrolled, can lead to device malfunction and permanent stiction that negatively impacts on reliability. This dielectric charge accounts for a number of reliability issues in electrostatically actuated MEMS and hence is a major barrier to the commercialisation of many such devices; as in the case of RF switches. Researchers from UCD and UPC have developed this novel control method that improves the accuracy and resolution of all devices that use electrostatic actuation.
Rapid Prototype Manufacture of Polymeric Microfluidics inserts and Devices
The novel technology developed by the Microfluidic Group in UCD, funded by Enterprise Ireland allows the rapid manufacture of low-cost microfluidic inserts suitable for either small multiple prototype runs or for scale up polymer manufacture of 10,000+ parts using medical polymers, taking less than 1 hour for the manufacture and preparation of industrially viable inserts with features as low as 100 micron. A key issue for production of plastic microfluidics is fabrication of inverted microstructured tools. Mass production tools must be strong, durable, with the required feature size and aspect ratio, maintain a good demolding capability with a feasible draft angle, appropriate surface finish and a good cost/performance ratio. Normally technologies are slow (days) and/or expensive requiring the manufacture .
Iodine-Free Electrolyte for DyeSensitized Solar Cells
Dye-Sentitized Solar Cells (DSSCs) are an emerging low-cost third generation photovoltaic technology particularly suited for efficient light to-electricity conversion in indoors low-light environments. Electrolyte leakage due to the corrosive nature of iodine/iodide-containing electrolytes is currently the key issue preventing the technology’s productisation and wider deployment.
Epigenetic Therapy for Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy (HCM) is the most common of hereditary cardiac conditions and is related to mutations in sarcomere proteins, the most frequent of which is MYBPC (cardiac myosin protein C). While MYPB-C mutations are associated with HCM, there is a marked heterogeneity in phenotypic responses to mutations of this gene, even within families, and this could be explained by epigenetic factors such as hypermethylation. UCD researchers have shown that the DNA methylation inhibitor 5-azacitidine (5-aza) improves cardiac function, including hypertrophy and diastology, in a murine animal model (SHR, spontaneously hypertensive rat, model) and this is associated with up-regulation of MYBP-C, and more surprisingly actin alpha1 skeletal muscle (ACTA1), gene expression in cardiomyocytes. Therefore, DNA methylation inhibitors may represent a novel therapeutic strategy for the prevention and treatment of HCM, in particular the Orphan indications HOCM and FHCM. 5-aza is a hypomethylation agent that could be repurposed for Orphan indications in HCM.
Microfluidic Cell Culture Platform for Cell Based Assays
UCD researchers have developed a microfluidic cell culture platform for cell-based assays that simultaneously exposes cells to multiple linear concentration gradients formed in different directions. Diffusion-based, stable gradients can be formed within one hour and can be maintained for days without inducing shear stresses on the cells. The platform is suitable for medium throughput screening with brightfield or fluorescence visualization/quantitation of cells via microscopic imaging or a plate reader. Combinatorial drug screening and dose optimization studies can be performed, where equal numbers of cells are exposed to combinations of each compound at defined concentrations. Other potential applications include cell migration, live-cell tracking and post-fixation immunocytochemistry.
Novel Topical Therapeutic for Retinal Vascular Disease
UCD has developed novel, small molecule, anti-angiogenic compounds to offer patients and clinicians cost-effective, easily administered, safe and sustainable therapeutics to prevent blindness from retinal vascular diseases. The retinal therapeutics market is estimated at $3 billion (2012); it is a high growth market with significant unmet need. The dramatic entry of Lucentis (anti-VEGF antibody intravitreal drug) into the market in 2007 and the success of anti-angiogenic drugs have highlighted the opportunity for products in the retinal disease market. The entry of topical or slow release preparations into the market would eliminate the current practice of repeated intravitreal injections and the associated safety risks and clinical burden. In addition, there is a cohort of patients unresponsive to current treatments, underscoring the need for new therapeutics.
Prognostic test for the early detection of Endometritis in cattle.
Early detection of endometritis in livestock to enable successful intervention and treatment of the disease before it becomes an economic burden. Substantial economic loss occurs within dairy herds as a consequence of persistent endometritis. The resulting treatment costs, reduced fertility, increased cull rates and animal welfare consequences collectively cost over €15 billion globally per annum. The key to the reduction of these costs is early diagnosis but currently detection methods are only effective after the consequences of persistent uterine infection have already occurred. Currently there are no reliable early diagnostic or prognostic tests for animals that go on to develop chronic or subclinical endometritis. Researchers within UCD and NIBRT have developed a prognostic/diagnostic assay for the early detection of endometritis in livestock based on the detection of specific changes in glycosylation patterns that are highly correlated with the occurrence of uterine infection. This opportunity has the potential to work as a valuable prognostic tool affording farmers and veterinary practitioners the ability to intervene before the damage caused by clinical disease manifests itself. It also has the potential to be used as a phenotypic marker to enhance innate disease resistance through selective breeding programmes.
Tamper-proof food traceability through direct imprinting of smartphone-readable data matrices onto food.
Owing to the growing concern nationally and internationally regarding food traceability and the authenticity of food products (their origin, processing and downstream delivery and storage), emphasis on tamper proof mechanisms of reliably determining this information is paramount within the food sector. Country of Origin and method of reading are major issues for the food industry, regulatory bodies and the consumer alike, particularly for internationally traded foods such as meat. Labels can be tampered with and products repackaged undermining consumer confidence and putting the consumer at risk of health related issues. To address these issues, researchers within University College Dublin have developed a novel labelling system based on the direct laser imprinting of data matrix or other formats onto a food product such as chicken breast fillets, prime beef cuts etc, using a novel food grade marking system. Using this technology, it affords the food processor, the retailer and the consumer the opportunity to access on-the-spot (real time) product information thus offering a secure tamper-proof food traceability systems for both local and global use.
Use these powerful search and filter tools to discover the licensing opportunities you are looking for.
Keep an eye here for the number of returned opportunities
The best matching results of your search and filters are displayed here. For further details on opportunity, click on the opportunity name!
Click here to view a summary of this opportunity.View Topics Back To Start